Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenyang Tongluo Decoction is a traditional Chinese herbal formula used primarily in Traditional Chinese Medicine (TCM) for the treatment of conditions associated with "cold" and "stasis" syndromes, such as peripheral neuropathy and systemic sclerosis-related skin fibrosis. The decoction is typically composed of multiple herbs designed to warm yang (the body's vital energy), promote blood circulation, unblock meridians (channels), and alleviate pain or numbness. Mechanistically, studies suggest that similar formulas can exert anti-fibrotic effects by promoting apoptosis and inhibiting proliferation of fibroblasts through down-regulation of cell cycle proteins like cyclin D1 and survivin[1][2]. Clinical observations indicate its use as an external wash or fumigation therapy for chemotherapy-induced peripheral neurotoxicity[3]. The exact composition may vary by practitioner or region.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wenyang Tongluo Decoction.